The anti-YKL-40 monoclonal antibody had no effect on the proliferation rate of LOX melanoma cells in vitro (which has also been described for colon and breast cancer cells [16]) and in vivo (Figure 6A), making a direct effect on the tumor cells in vivo unlikely. This evidence concerns the gene CHI3L1 and breast carcinoma.